Detalles de la búsqueda
1.
Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol;
29(1): 163-173, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34383185
2.
Barriers to Referral for Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Identified Using a Tailoring Grid Methodology: Interviews with Stakeholders in New York State.
J Surg Res;
267: 235-242, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34157492
3.
Characterizing the Patient Experience of CS/HIPEC Through In-Depth Interviews with Patients: Identification of Key Concepts in the Development of a Patient-Centered Program.
Ann Surg Oncol;
26(4): 1063-1070, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30603814
4.
Value-Based Health Care: The Fine Balance of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS ± HIPEC).
Ann Surg Oncol;
30(13): 7926-7928, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37782410
5.
ASO Author Reflections: Opportunities for Improving HIPEC Outcomes.
Ann Surg Oncol;
29(1): 174, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581920
6.
Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons.
Ann Surg Oncol;
24(4): 923-930, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27900630
7.
Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5â¯years.
Surg Oncol;
28: 116-120, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30851884
Resultados
1 -
7
de 7
1
Próxima >
>>